查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年各服务（个人、非个人促销）、最终用途（製药公司、生物製药公司）、地区、细分趋势的合同销售代理市场规模、份额、趋势分析报告
市场调查报告书
商品编码
1233195

2023-2030 年各服务（个人、非个人促销）、最终用途（製药公司、生物製药公司）、地区、细分趋势的合同销售代理市场规模、份额、趋势分析报告

Pharmaceutical Contract Sales Organizations Market Size, Share & Trends Analysis Report By Services (Personal, Non-personal Promotion), By End-use (Pharma, Biopharma Companies), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

合同营销代理市场的增长和趋势

Grand View Research, Inc. 的一份新报告显示，全球合同销售代理市场规模从 2023 年到 2030 年将以 8.4% 的复合年增长率增长，到 2030 年将达到 163%。预计将达到美国10亿美元。

合同销售组织 (CSO) 对寄售新技术的采用率很高，最终用户对扩大生物製药和小分子药物的销售越来越感兴趣，并且对与内部相关的成本削减需求迅速增加销售是支持该行业增长的一些关键因素。 近年来，新药上市数量不断增加。

例如，根据 IQVIA 研发趋势报告，2021 年全球将推出 84 种新的活性物质，比过去五年翻了一番。 预计全球药物上市的增加将提振对合同销售服务的需求，这可能会支持该行业的增长。 处方药的销售额正在稳步增长。 例如，根据 Evaluate Pharma 的数据，2021 年全球处方药总销售额将达到 1.66 万亿美元，到 2028 年将达到 1.612 万亿美元。 预计製药公司不断增长的销售需求将推动大流行后对製药业 CSO 服务的需求。

医药合同营销代理市场报告亮点

  • 在服务方面，个人促销部门在 2022 年主导了该行业。 由于製药公司研发活动的增加，预计新药上市数量将增加，预计批准将支持该领域的增长。
  • 由于製药公司在产品销售方面的激烈竞争推动了对支持销售业务的高效团队的需求，因此製药最终用途部门在 2022 年的收入份额最大。
  • 北美在 2022 年的收入份额最大。 该地区在过去几年中推出了大量药物，主要是在美国，这是支持该地区增长的关键因素之一。
  • 此外，该地区的公共机构正在稳步加大资金支持研发活动的力度。 这进一步推动了该地区的增长。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 服务
    • 最终用途
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析（模型 1）
    • 批量价格分析（模型 2）
  • 二级信息列表
  • 主要信息列表
  • 目的

第 2 章执行摘要

  • 市场展望

第 3 章合同销售组织 (CSO) 市场的变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 相关/子公司市场前景
  • 市场动态
    • 市场驱动因素分析
      • 增加了药物研发活动并增加了药物管线
      • 製药公司对促进产品销售的兴趣增加
      • 数字技术在医药合同销售组织中的应用
    • 市场製约因素分析
      • 与外包相关的质量问题
    • COVID-19 的影响和恢復分析
    • 行业分析 - 波特五力模型
    • PESTLE 分析

第 4 章合同销售组织 (CSO) 市场：服务细分分析

  • 合同销售组织 (CSO) 市场：定义和范围
  • CSA 市场 (CSO) 市场：服务市场份额分析，2022 年和 2030 年
    • 个人宣传
      • 促销销售团队
      • 大客户管理
      • 职位空缺管理
    • 非个人促销
      • 医疗解决方案
      • 远程医疗科学联络员
      • 护士（临床）教育家
      • 其他

第 5 章合同销售组织 (CSO) 市场：最终用途细分分析

  • 合同销售组织 (CSO) 市场：定义和范围
  • 合同销售组织 (CSO) 市场：最终用途市场份额分析，2022 年和 2030 年
    • 製药公司
    • 生物製药公司

第 6 章合同销售组织 (CSO) 市场：区域分析

  • 合同销售组织 (CSO) 市场：区域市场份额分析，2022 年和 2030 年
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳大利亚
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
      • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第七章竞争格局

  • 中美国际控股有限公司
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • 阿克塞勒斯
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • EPS 公司。
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • QFR 解决方案
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • 马比科
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Mednext Pharma 私人有限公司
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Peak Pharma Solutions Inc.
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • 艾昆纬公司
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Promoveo 健康
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
  • Syneous 健康
    • 公司简介
    • 财务业绩
    • 服务基准
    • 战略举措
Product Code: GVR-4-68040-034-7

Pharmaceutical Contract Sales Organizations Market Growth & Trends:

The global pharmaceutical contract sales organizations market size is expected to reach USD 16.3 billion by 2030, registering a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. High adoption of new technologies for contract sales by pharmaceutical contract sales organizations (CSO), an increase in the interest among end-users to increase the sales of biopharmaceutical and small molecule drugs, and the surge in demand for reducing the cost associated with in-house sales are some of the key factors supporting the growth of the industry. Over the years, the number of new drug launches has increased.

For instance, according to the IQVIA report on R&D trends, 84 new active substances were launched globally in 2021, which was double as compared to the last five years. The increase in drug launches globally is expected to improve the demand for contract sales services, which is likely to support industry growth. Prescription drug sales are witnessing a steady rise. For instance, according to Evaluate Pharma, worldwide total prescription drug sales accounted for USD 1,066 billion in 2021 and will reach USD 1,612 billion by 2028. The growing demand for sales among pharmaceutical companies is expected to improve the demand for CSO services for pharmaceuticals in the post-pandemic period.

Pharmaceutical Contract Sales Organizations Market Report Highlights:

  • Based on service, the personal promotion segment dominated the industry in 2022. A rise in the R&D activities of pharmaceutical companies is expected to increase the number of new drug launches, and approvals are expected to support the segment growth
  • The pharmaceutical companies end-use segment held the largest revenue share in 2022 due to the high competition among pharmaceutical companies in product sales, promoting the demand for an efficient team to support their sales activities
  • North America held the largest revenue share in 2022. A significant number of drugs were launched in the region in the previous years, especially in the U.S., which is one of the key factors supporting the region's growth
  • Moreover, the region's public organization is steadily focused on supporting R&D activities by providing funding. This has further supported the region's growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Service
    • 1.1.2. End-use
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3
    • 1.9.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Pharmaceutical Contract Sales Organization Market (CSO) Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increase the R&D activities on drugs and increase in the drug pipeline
      • 3.2.1.2. Growing interest of pharmaceutical companies to increase the sales of the products
      • 3.2.1.3. Adoption of digital technologies by Pharmaceutical Contract Sales Organizations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Quality issues associated with outsourcing
    • 3.2.3. Covid-19 Impact & Recovery Analysis
    • 3.2.4. Industry Analysis - Porter's Five Forces
    • 3.2.5. PESTLE Analysis

Chapter 4. Pharmaceutical Contract Sales Organization Market (CSO): Service Segment Analysis

  • 4.1. Pharmaceutical Contract Sales Organization Market (CSO) Market: Definition & Scope
  • 4.2. Pharmaceutical Contract Sales Organization Market (CSO) Market: Service Market Share Analysis, 2022 & 2030
    • 4.2.1. Personal Promotion
      • 4.2.1.1. Personal promotion market, 2018 - 2030 (USD Million)
      • 4.2.1.2. Promotional sales team
      • 4.2.1.2.1. Promotional sales team market, 2018 - 2030 (USD Million)
      • 4.2.1.3. Key account management
      • 4.2.1.3.1. Key account management market, 2018 - 2030 (USD Million)
      • 4.2.1.4. Vacancy Management
      • 4.2.1.4.1. Vacancy Management market, 2018 - 2030 (USD Million)
    • 4.2.2. Non-Personal Promotion
      • 4.2.2.1. Non-Personal promotion market, 2018 - 2030 (USD Million)
      • 4.2.2.2. Medical affairs solutions
      • 4.2.2.2.1. Medical affairs solutions market, 2018 - 2030 (USD Million)
      • 4.2.2.3. Remote medical science liaisons
      • 4.2.2.3.1. Remote medical science liaisons market, 2018 - 2030 (USD Million)
      • 4.2.2.4. Nurse (clinical) educators
      • 4.2.2.4.1. Nurse (clinical) educators market, 2018 - 2030 (USD Million)
      • 4.2.2.5. Others
      • 4.2.2.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Sales Organization Market (CSO): End-use Segment Analysis

  • 5.1. Pharmaceutical Contract Sales Organization Market (CSO) Market: Definition & Scope
  • 5.2. Pharmaceutical Contract Sales Organization Market (CSO) Market: End Use Market Share Analysis, 2022 & 2030
    • 5.2.1. Pharmaceutical Companies
      • 5.2.1.1. Pharmaceutical companies Market, 2018 - 2030 (USD Million)
    • 5.2.2. Biopharmaceutical Companies
      • 5.2.2.1. Biopharmaceutical companies Market, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Contract Sales Organization Market (CSO): Regional Analysis

  • 6.1. Pharmaceutical Contract Sales Organization Market (CSO): Regional market share analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Market estimates and forecast, 2018 - 2030
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Market estimates and forecast, 2018 - 2030
    • 6.2.3. Canada
      • 6.2.3.1. Canada Market estimates and forecast, 2018 - 2030
  • 6.3. Europe
    • 6.3.1. Europe Market estimates and forecast, 2018 - 2030
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Market estimates and forecast, 2018 - 2030
    • 6.3.3. Germany
      • 6.3.3.1. Germany Market estimates and forecast, 2018 - 2030
    • 6.3.4. France
      • 6.3.4.1. France Market estimates and forecast, 2018 - 2030
    • 6.3.5. Italy
      • 6.3.5.1. Italy Market estimates and forecast, 2018 - 2030
    • 6.3.6. Spain
      • 6.3.6.1. Spain Market estimates and forecast, 2018 - 2030
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Market estimates and forecast, 2018 - 2030
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Market estimates and forecast, 2018 - 2030
    • 6.3.9. Norway
      • 6.3.9.1. Norway Market estimates and forecast, 2018 - 2030
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030
    • 6.4.2. Japan
      • 6.4.2.1. Japan Market estimates and forecast, 2018 - 2030
    • 6.4.3. China
      • 6.4.3.1. China Market estimates and forecast, 2018 - 2030
    • 6.4.4. India
      • 6.4.4.1. India Market estimates and forecast, 2018 - 2030
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
    • 6.4.6. Australia
      • 6.4.6.1. Australia Market estimates and forecast, 2018 - 2030
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Market estimates and forecast, 2018 - 2030
  • 6.5. Latin America
    • 6.5.1. Latin America Market estimates and forecast, 2018 - 2030
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Market estimates and forecast, 2018 - 2030
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Market estimates and forecast, 2018 - 2030
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Market estimates and forecast, 2018 - 2030
      • 6.6.MEA
    • 6.6.1. MEA Market estimates and forecast, 2018 - 2030
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Market estimates and forecast, 2018 - 2030
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
    • 6.6.4. UAE
      • 6.6.4.1. UAE Market estimates and forecast, 2018 - 2030
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Market estimates and forecast, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. CMIC HOLDINGS Co., LTD
      • 7.1.1.1. Company overview
      • 7.1.1.2. Financial performance
      • 7.1.1.3. Service benchmarking
      • 7.1.1.4. Strategic initiatives
  • 7.2. Axxelus
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Service benchmarking
      • 7.2.1.4. Strategic initiatives
  • 7.3. EPS Corporation.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Service benchmarking
      • 7.3.1.4. Strategic initiatives
  • 7.4. QFR SOLUTIONS
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Service benchmarking
      • 7.4.1.4. Strategic initiatives
  • 7.5. MaBico
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Service benchmarking
      • 7.5.1.4. Strategic initiatives
  • 7.6. Mednext Pharma Private Limited
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Service benchmarking
      • 7.6.1.4. Strategic initiatives
  • 7.7. Peak Pharma Solutions Inc.
      • 7.7.1.1. Company overview
      • 7.7.1.2. Financial performance
      • 7.7.1.3. Service benchmarking
      • 7.7.1.4. Strategic initiatives
  • 7.8. IQVIA, Inc.
      • 7.8.1.1. Company overview
      • 7.8.1.2. Financial performance
      • 7.8.1.3. Service benchmarking
      • 7.8.1.4. Strategic initiatives
  • 7.9. Promoveo Health
      • 7.9.1.1. Company overview
      • 7.9.1.2. Financial performance
      • 7.9.1.3. Service benchmarking
      • 7.9.1.4. Strategic initiatives
  • 7.10. Syneous Health
      • 7.10.1.1. Company overview
      • 7.10.1.2. Financial performance
      • 7.10.1.3. Service benchmarking
      • 7.10.1.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Pharmaceutical CSO market outlook, 2018 - 2030
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (Current & future impact)
  • Fig. 11 Market restraint relevance analysis (Current & future impact)
  • Fig. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Pharmaceutical CSO market: Service outlook key takeaways
  • Fig. 15 Pharmaceutical CSO market: Service movement analysis
  • Fig. 16 Personal Promotion market, 2018 - 2030 (USD Million)
  • Fig. 17 Promotional sales team market, 2018 - 2030 (USD Million)
  • Fig. 18 Key account management market, 2018 - 2030 (USD Million)
  • Fig. 19 Vacancy management market, 2018 - 2030 (USD Million)
  • Fig. 20 Non-personal Promotion market, 2018 - 2030 (USD Million)
  • Fig. 21 Medical affairs solutions market, 2018 - 2030 (USD Million)
  • Fig. 22 Remote medical science liaisons market, 2018 - 2030 (USD Million)
  • Fig. 23 Nurse (clinical) educators market, 2018 - 2030 (USD Million)
  • Fig. 24 Others market, 2018 - 2030 (USD Million)
  • Fig. 25 Pharmaceutical CSO market: End-use outlook key takeaways
  • Fig. 26 Pharmaceutical CSO market: End-use movement analysis
  • Fig. 27 Pharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 28 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
  • Fig. 29 Regional marketplace: Key takeaway
  • Fig. 30 Pharmaceutical CSO market regional outlook, 2020 & 2028
  • Fig. 31 North America Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 33 Canada Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 34 Europe Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 35 Germany Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 36 France Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 37 U.K. Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 38 Spain Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 39 Italy Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 44 Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 46 India Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East & Africa Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 57 UAE Pharmaceutical CSO market, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait Pharmaceutical CSO market, 2018 - 2030 (USD Million)